Bibliografía del artículo
1. Go MF. Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 16(Suppl 1):S3-15, 2002.
2. NIH Consensus Statement. Helicobacter pylori in peptic ulcer disease. 12:1-23, 1994.
3. Vaira D, Gatta L, Ricci C, D'Anna L, Miglioli M. Helicobacter pylori: diseases, tests and treatment. Digest Liver Dis 33:788-94, 2001.
4. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784-9, 2001.
5. Blaser MJ, Chyou PH, Normura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 55:562-5, 1995.
6. Czinn SJ. Helicobacter pylori infection: detection, investigation, and management. J Pediatr 146(Suppl 3):S21-6, 2005.
7. Kato S, Sherman PM. What is new related to Helicobacter Pylori infection in children and teenagers? Arch Pediatr Adolesc Med 159:415-21, 2005.
8. Uc A, Chong SKF. Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in children. J Pediatr Gastroenterol Nutr 34:281-5, 2002.
9. Tindberg Y, Blennow M, Glanstrom M. Clinical symptoms and social factors in a cohort of children spontaneously clearing Helicobacter pylori infection. Acta Pediatrica 88:631-5, 1999.
10. Rothenbacher D, Bode G, Adler G, Brenner H. History of antibiotic treatment and prevalence of Helicobacter pylori infection among children: results of a population-based study. J Clin Epidemiol 51:267-71, 1998.
11. Magista AM, Ierardi E, Castellaneta S, et al. Helicobacter pylori status and symptom assessment two years after eradication in pediatric patients from a high prevalence area. J Pediatr Gastroenterol Nutr 40:312-8, 2005.
12. Malfertheiner P, Megraud F, O'morain C, et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht III Consensus Report. Gut 2007 [Epub ahead of print].
13. Sherman P, Hassall E, Hunt RH, et al. Canadian Helicobacter Study Group Consensus Conference on the approach to Helicobacter pylori infection in children and adolescents. Can J Gastroenterol 13:553-9, 1999.
14. Gold BD, Colletti RB, Abbott M, et al. North American Society for Pediatric Gastroenterology and Nutrition. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 31:490-7, 2000.
15. Oderda G, Rapa A, Bona G. A systematic review of Helicobacter pylori eradication treatment schedules in children. Aliment Pharmacol Ther 14:56-60, 2000.
16. Oderda G, Shcherbakov P, Bontems P, et al; On behalf of the European Pediatric Task Force on Helicobacter pylori. Results from the Pediatric European Register for Treatment of Helicobacter pylori (PERTH). Helicobacter 12:150-6, 2007.
17. Kato S, Konno M, Maisawa S, et al. Results of triple eradication therapy in Japanese children: a retrospective multicenter study. J Gastroenterol 39:838-43, 2004.
18. Gottrand F, Kalach N, Spyckerelle C, et al. Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial. J Pediatr 139:664-8, 2001.
19. Oderda G, Marinello D, Lerro P, et al. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. Helicobacter 9:293-301, 2004.
20. Deltenre M, Ntounda R, Jonas C, et al. Eradication of Helicobacter pylori: Why does it fail? Ital J Gastroenterol Hepatol 30(Suppl 3):S326-8, 1998.
21. Koletzko S, Richy F, Bontems P, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 55:1711-6, 2006.
22. Huang JQ, Hunt RH. Are one-week anti-Helicobacter pylori treatments more effective in patients with peptic ulcer disease than in those with non ulcer dyspepsia? A meta-analysis. Am J Gastroenterol 93:1639, 1998.
23. Van Doorn LJ, Schneeberger PM, Nohuan N, Plaisier AP, Quint WGV, De Boer WA. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut 46:321-6, 2000.
24. Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 129:1414-9, 2005.
25. Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 17:719-26, 2003.
26. Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 14:715-8, 2000.
27. De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Digest Liver Dis 33:676-9, 2001.
28. De Francesco V, Della Valle N, Stoppino V, et al. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 19:1-6, 2004.
29. De Francesco V, Zullo A, Margotta M, et al. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. Aliment Pharmacol Ther 19:407-14, 2004.
30. Malfertheiner P, Megraud F, O'Morain C, et al; European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16:167-80, 2002.
31. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97:2744-9, 2002.
32. Cremonini F, Canducci F, Di Caro S, et al. Helicobacter pylori treatment: a role for probiotics? Dig Dis 19:144-7, 2001.
33. Fuller R. Probiotics in human medicine. Gut 32:439-42, 1991.
34. Nista EC, Candelli M, Cremonini F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 20:1181-8, 2004.
35. Lionetti E, Miniello VL, Castellaneta SP, et al. The effect of oral administration of Lactobacillus reuteri on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 24(10):1461-8, 2006.
36. Sharara AI, Chaar HF, Racoubian E, et al. Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection. Helicobacter 9:255-61, 2004.
37. Permin H, Andersen L.P. Inflammation, immunity, and vaccines for Helicobacter infection. Helicobacter 10(Suppl 1):S21-5, 2005.